Medical Advocates

Ethics and
Infectious Diseases
  Ethical Challenges
Screening/Testing
Refusal of Care/Services
Detention

Patient Exploitation
Compulsory Treatment
Decision-Making
Reproduction
Transplants
End-of-Life Care
Enteral Nutrition
Professional Associations
National Challenges         Sterilization
Bioterrorism                     Prison Challenges
HIV Exceptionalism           Conflicts of Interest

Pharmaceutical Industry   Pregnancy
HIV Prevention   
Stigma
Physician Reimbursement 
Ethics and Disease Challenges and Duties
HIV Cure
Ebola Virus Disease
Executions







 

Ethics Main Page Main New and Noteworthy Home Page

HCV Main Page Main New/Newsworthy    Home Page    

Last Update:  January 31, 2018
 
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General/Miscellaneous Reports
 

 
Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort
Alvarez-Ossorio MJ, Sarmento E  et al
J Viral Hepat. 2018 Jan 28
Abstract

Acute alveolar haemorrhage in hepatitis C-related cryoglobulinaemic vasculitis.
Rajkumar T, Vilayur E.
BMJ Case Rep. 2018 Jan 4;2018.
Abstract

Response to Portal vein thrombosis after hepatitis C eradication with direct acting antiviral therapy.
Tripodi A.
Liver Int. 2018 Jan;38(1):186.
Abstract

Efficacy and safety of sofosbuvir-based, interferon-free therapy : The Management of rheumatologic extrahepatic manifestations associated with chronic hepatitis C virus infection.
Shahin AA, Zayed HS, Said M, Amer SA.   
Z Rheumatol
. 2017 Aug 9.
Abstract

Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-acting Antivirals.
Bonacci M, Lens S, Londoño MC, et al
Clin Gastroenterol Hepatol
. 2016 Oct 7.
Abstract

FULL-TEXt ARTICLE
Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection.
Burke Schinkel SC, Carrasco-Medina L, Cooper CL, Crawley AM.
PLoS One
. 2016 Jun 17;11(6):e0157055.
Paper

FULL-TEXT ARTICLE
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage.
Valva P, Ríos DA, De Matteo E, Preciado MV.
World J Gastroenterol
. 2016 Jan 28;22(4):1367-81.
Paper

Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy.
Marano M, Vespasiani Gentilucci U et al 
Metab Brain Dis
. 2015 Aug 27.
Abstract

Micro-RNA-122 levels in acute liver failure and chronic hepatitis C.
Dubin PH, Yuan H, Devine RK,et al  
J Med Virol. 2014 Jun 4.
Abstract

FULL-TEXT ARTICLE
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.
Zampino R, Marrone A, Restivo L, et al
World J Hepatol
. 2013 Oct 27;5(10):528-540.
Paper

Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease.
Himoto T, Tani J, Miyoshi H, Morishita A,, et al 
Diabetol Metab Syndr
. 2013 Sep 9;5(1):51.
Abstract

Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes.
Pattullo V, McAndrews MP, Damyanovich A, Heathcote EJ.
Liver Int. 2011 Aug;31(7):1028-38
Abstract

Lymphocytosis as a predictor of poor response to treatment of hepatitis C.
Martinez-Camacho A, Khaoustov VI, Adam E,
Gastroenterol Clin Biol. 2010 Dec 22.
Abstract

Cutaneous sarcoidosis in a woman with chronic hepatitis C and interferon therapy:a case report.
Song K, Das K.
Acta Cytol
. 2010 Sep-Oct;54(5 Suppl):863-6.
Abstract

Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes?
Peters L, Rockstroh JK.
Curr Opin HIV AIDS
. 2010 Nov;5(6):517-23.
Abstract

Prevalence and Challenges of Liver Diseases in Patients with Chronic Hepatitis C Virus
Infection.
Jacobson IM, Davis GL, El-Serag H, et al
Clin Gastroenterol Hepatol. 2010 Aug 13
Abstract

 


Biliary Disorders
 

  Role of a Short-Term Stent-Trial in a Patient with Biliary Stricture and Portal Hypertensive Biliopathy: Long-Term Outcome Result.
Cantù P, Bezzio C.
Dig Dis Sci. 2010 Aug 19.
Abstract
 

Cholestatic Hepatitis
 

     Journal Papers, Abstracts, and Commentaries
 
 
Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: Report of a case.
Fukuhara T, Morita K, Takeishi K,  et al
Surg Today
. 2010 Oct;40(10):982-985
Abstract

Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis.
Saleh F, Ko HH, Davis JE, Apiratpracha W, et al
Ann Hepatol. 2007 Jul-Sep;6(3):186-9
Abstract